|
|
|
|
| 6th European Congress on Tropical Medicine and International Health | | September 6 - 10, 2009 Verona, Italy | | 1st Mediterranean Conference on Migration and Travel Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Meet the Professor
Room 1 | 08.30 - 09.15
Ajit Lalvani (United Kingdom)
Immunodiagnosis of TB: from principles to practice |
| | Clinical Session
Room 2 | 08.30 &ndash 09.15
Jef Van den Ende (Belgium)
The Kabisa computer training programme for tropical medicine
|
| | Meet the Professor
Room 3 | 08.30 – 09.15
Eric Caumes (France)
Tropical skin conditions |
| | Meet the Professor
Room 4 | 08.30 – 09.15
Marleen Boelaert (Belgium)
Kala-azar elimination in the Indian subcontinent: what’s the evidence?
|
| | Meet the Professor
Room 5 | 08.30 – 09.15
María Guadalupe Guzmán (Cuba)
What’s new on dengue pandemic? |
| |
|
|
|
| | T1 Building a Common Framework on Human Rights, Equity and Access to Care
Auditorium | 09.30 – 11.00 | Plenary Session
| | | Chairs: Zeno Bisoffi (Italy), Gunnar Kvale (Norway)
| | | | Keynote Speakers: | | | | David Sanders (South Africa)
Making Public Health matter: Research and Advocacy to address Global Health Challenges
|
| | Hans V. Hogerzeil (World Health Organization)
Human rights approach to health policy: the case of essential medicines |  | | Gianni Tognoni (Italy)
Ethics and health care: Is the ethical debate only an issue of clinical research? | | |
|
|
|
| | T2P1 Patho -physiology & Severe Malaria –
From basic knowledge to new therapeutic aproaches
Auditorium | 11.30 – 13.00 | Parallel Session
| | | Chair: Donatella Taramelli (Italy)
|
| | Keynote Speakers:
Paolo Arese (Italy)
Pathogenesis of severe malaria anaemia
|
| | Nick White (Thailand)
Treatment of severe malaria in adults and children: new evidences and state of the art | | | T2P1-01
Endoglin in African Children with Plasmodium falciparum Malaria: a novel Player in Severe Malaria Pathogenesis?
A. Dietmann, R. Helbok, P. Lackner, M. Fischer, M. Reindl, B. Lell, S. Issifou, P. Kremsner and E. Schmutzhard |
| | T2P1-02
Cerebral malaria and epilepsy
M. Dumas, E. B. Ngoungou, P.-M. Preux | | | T2P1-03
Neuroprotective roles and in vivo significance of Neuroglobin in Cerebral Malaria
B. Della Valle, C. Hempel, J. Kurtzhals and M. Penkowa |
| | T2P1-04
Cardiac function impairment in malaria
J. P. Cramer, J. Herr, D. Wichmann, S. Ehrhardt, S. Schmiedel and G. D. Burchard |
| | T2P1-05
Intermittent preventive treatment of malaria decreases the anti-Plasmodium schizont antibody response of Senegalese children
D. Boulanger, J. B. Sarr, F. Fillol, B. Cisse, C. Sokhna, G. Riveau, K. Bork Simondon, J.-F. Tape, B. Greenwood, F. Simondon and F. Remoue
| | |
|
|
|
| | T1P1 Removing barriers to access to quality care:
successes and failures
Room 1 | 11.30 – 13.00 | Parallel Session | | | Chair: Hans Hogerzeil (World Health Organization)
|
| | | Keynote Speaker:
Anne Mills (United Kingdom)
Successes and failures on overcoming barriers to access to quality care |
| | T1P1-01
Reducing mortality in Mali through free health care for children and pregnant women and enhanced malaria care
F. Ponsar, S. Mancini, M. Van Herp, P. Firmenich, L. Kakudji and M. Philips |
| | T1P1-02
Impact of Performance Based Financing on Maternal Health service in Rwanda: a quasi-experimental study
P. Basinga | | | T1P1-03
Comparison of medical treatment between community-based insurance members and non-members in primary health care in Nouna, Burkina Faso
A. Souares, G. Epp-Graack, G. Savadogo, D. Parmar, A. Sié and R. Sauerborn
|
| | T1P1-04
Health sector reforms and quality of care at the district level in Tanzania
V. Zinnen, A. Mwisongo and A. Robert
|
| | T1P1-05
Abolish user fees: a major difference in increased coverage of essential reproductive health care
M. Philips, F. Ponsar and S. Simons |
| | T1P1-06
Ensuring access to first line care in a changing environment: the experience of the Dragones-area in Centrohabana, Cuba (2004 – 2007)
M. Guerra, A. Rodriguez, P. De Vos, M. Bonet and P. Van der Stuyft
|
| | T1P1-07
National Health Insurance and socioeconomic status in a rural district in Ghana
N. Sarpong, W. Loag, J. Fobil, Y. Adu-Sarkodie, J. May and N. G. Schwarz |
| |
|
|
|
| | T3P1 HIV treatment and prevention
Room 3 | 11.30 – 13.00 | Parallel Session | | | Introduction by Chair: Peter Piot (United Kingdom)
|
| | | T3P1-01
Adverse Events Associated to HAART in Burkina Faso
S. Odolini, E. Focà, F. Buelli, S. Caligaris, J. Simporé, J. Semporé, K. Sanogo, S. Pignatelli, V. Pietra and F. Castelli
|
| | T3P1-02
Dyslipidaemia in Patients on First-line ART in India – A Prospective Cohort Study
V. K. Sashindran, S. Kumar, A. Kumar, K. Namgyal and R. Dabas
|
| | T3P1-03
How to improve women’s and partner’s participation to prenatal HIV counseling in rural and urban areas in Kivu, Democratic Republic of Congo?
C. Schirvel, E. Bahizire, E. Bahati, G. Bisimwa, M. Dramaix and P. Donnen
| | | T3P1-04
Viral and host factors associated with high HIV-1 viral load setpoint in adult
seroconverters from Mbeya Region, Tanzania
M. Pritsch, E. Saathoff, C. Geldmacher, R. N. Koehler, R. N. Koehler, L. Maboko, L. Maganga, S. Geis, F. E. McCutchan, G. H. Kijak, J. H. Kim, M. A. Arroyo, M. Gerhardt, S. Tovanabutra, M. L. Robb, C. Williamson, N. L. Michael and M. Hoelscher |
| | T3P1-05
AIDS in Bosnian children
A. Bajraktarevic, S. Trninic, Z. Mulalic, A. Beganovic, L. Sporisevic, A. Selimovic and I. Suljevic
|
| | T3P1-06
Behavioral aspects of HIV prevention and care in Indonesia. A plea for a multi-disciplinary, theory- and evidence-based approach
W. L. Pinxten and E. N. Sumintardja | | | T3P1-07
Social Networks and Sustainable Antiretroviral Provision to Displaced Communities in Northern Uganda
M. Wilhelm-Solomon | | | T3P1-08
Assessing the knowledge and behaviour towards HIV & AIDS among youth in Northern Uganda: a cross-sectional survey
L. Cicciò, M. Makumbi and D. Sera | | |
|
|
|
| | T4P1 Buruli Ulcer, other Tropical Diseases
Room 4 | 11.30 – 13.00 | Parallel Session
| | | Chair: Eduardo Gotuzzo (Peru)
|
| | | Keynote Speaker:
Thomas Junghanss (Germany)
Progress in treating Buruli Ulcer
|
| | T4P1-01
Antimycobacterial screening of plants from Benin on Mycobacterium ulcerans, the causal agent of Buruli ulcer
A. Yemoa, A. Martin, J. Gbenou, D. Affolabi, R. C. Johnson, J. Djego, M. Moudachirou, A. Bigot, S. Anagonou, F. Portaels and J. Quetin-Leclercq | | | T4P1-02
Cost-effective strategy for confirmation of Mycobacterium ulcerans disease (Buruli ulcer) in low-resource and endemic settings
D. Affolabi, N. Sanoussi, N. Senou, F. Portaels and S. Anagonou |
| | T4P1-03
Features of 2006 cholera outbreak in Pemba island, Zanzibar, United Republic of Tanzania
A. Viganò, N. Pellissier, S.A. Ame, M. Omar, C.L. Chaignat and M. Pontello | | | T4P1-04
Angiostrongiliasis due to Parastrongylus (Angiostrongylus) cantonensis in Ecuador. First report in South America
T. Pincay, L. Garcia, E. Narvaez, O. Decker, L. Martini and J.-M. Moreira |
| | T4P1-05
Epidemiology of the Guinea Worm Disease at the Threshold of its Eradication
O. Morenikeji |
| | T4P1-06
Field evaluation of clinical features during Chikungunya outbreak in Mayotte 2005 – 2006: Implication for community-based active surveillance purposes
D. Sissoko, K. Ezzedine, A. Moendandzé, L. Filleul, P. Renault and D. Malvy
|
| | T4P1-07
Trends in the seroprevalence of antibodies against HTLV-1 among blood donors in a hospital of western Venezuela, 2004–2008
A. Rodriguez-Morales and A. Herrera-Martínez
|
| |
|
|
|
| | T6P1 Haemoragic Fevers and Dengue. New insights and preparednes to detect and control local outbreaks
Joint Sesion FESTMIH – ESCMID
Room 6 | 11.30 – 13.00 | Parallel Session | | | Chair: Giuseppe Ippolito (Italy)
|
| | | Keynote Speakers: | | | Paul Roddy (Médecins Sans Frontières – Spain)
Clinical manifestations and supportive treatment outcomes: Ebola haemorrhagic fever data from Bundibugyo, Uganda
|
| | Onder Ergonul (Turkey)
Haemorragic Fevers: Implications for tropical and temperate regions
| | | T6P1-01
Outbreak of Marburg Hemorrhagic Fever (MHF) in March 2005: a compromise between scientific methods and cultural beliefs; Uige province, Angola
E. De Vivo |
| | T6P1-02
Mechanisms of vascular leakage and bleeding during dengue infections
B. Wills
|
| | T6P1-03
Education level and the risk of dengue infection and Aedes aegypti infestation in an endemic area
F. Espinoza-Gomez, M. De la Cruz-Ruiz, O. A. Newton Sanchez, V. Melnikov, R. Curiel-Reyes, A. L. Amezcua-Sanchez and J. Rodriguez-Osorio | | | T6P1-04
Randomised primary health centre based interventions to improve the diagnosis and treatment of undifferentiated fever and dengue in Vietnam
L. P. Hoang, T. T. N. Tran, T. G. Phan, Q. H. Le, Q. B. Tran, V. N. Nguyen, N. Nagelkerke, P. J. de Vries and T. N. Tran |
| | T6P1-05
Evidence for a revised dengue classification: a multi-centre prospective study across Southeast Asia and Latin America
T. Jänisch, B. Wills, N. Alexander, B. Arana, A. Balmaseda, J. Bosco Siquueira Jr., I. Castelobranco, E. Dimaano, J. Farrar, R. Gaczkowski, M. Guzmán, E. Harris, T. T. Hien, O. Horstick, T. Junghanss, G. Knerer, K. Na-Bangchang, N. T. Hung, S. Kalayanarooj, L. Lum, A. Kroeger, E. Martinez Torres, C. Rocha, K. Rosenberger, L. H. Tan, T. T. Thuy, I. Villalobos and E. Villegas
| | |
|
|
|
| | EU support for partnership in international health research: principles , work in progress , and future perspectives (facilitated by the European Commission – Directorate General for Research)
Room 7 | 11.30 – 13.00 | Workshop | | | Objectives: - To provide an overview on EU-supported international health research and partnerships
- To highlight the policy coherence of research with overall EU policies (e.g. MDGs, sustainability agenda, Africa strategy)
- To highlight the principles of partnership and capacity building in international health research
- To introduce the 4th call of the 7th Framework Programme (FP7) |
| | | Chair: Ana Nieto (European Commission, DG Research) |
| | | Speakers: | | | Kevin McCarthy (European Commission, DG Research)
Policies, principles and objectives of EU-funded collaborative research for global health in the 7th Framework Programme
| | | Frederic Goyet (European Commission, DG Development)
Development and research – two worlds apart? Policy coherence in Europe’s approach to promote health for all
| | | Albrecht Jahn and Gianluca Quaglio (European Commission, DG Research)
International collaboration in public health and infectious disease control: The European research contribution and future calls
| | | Charles Mgone (EDCTP)
The EDCTP: a new model for equitable partnership in research for health
|
| | Shyam Sundar (India)
EU funding for international collaborative health research on neglected diseases: The Southern perspective |
| |
|
|
|
Neglected diseases and the Right to Health Care:
Euphemism or Optimism (Sanofi-Aventis)
Room 1 | 13.15 – 14.15 | Satellite Symposium | | | Chair: Leila Choukroune |
| | Keynote Speakers:
| | | François Chappuis
Neglected Tropical diseases: some of them are called "most" neglected | | | | Julio Arboleda-Florez Neglected Tropical diseases: are they neglected or unknown? | | | Robert Sebbag
CSR and neglected diseases: our corporate responsibility regarding the Right to Health Care everywhere in the world | | |
|
|
|
| | T2 Availability & affordability of ACTs
Auditorium | 14.30 – 16.00 | Main Session | | | | Chair: Christopher Whitty (United Kingdom) |
| | Speakers:
| | | Antonio Longo (Italy)
Basic research to improve supply of Artemisia derivatives
| | | Catherine Goodman (Kenya)
Subsidising ACT to Improve Access – Can the Market Deliver? |
| | George Jagoe (Medicines for Malaria Ventures)
Expanding Access: Private sector involvement, public sector responsibility | | |
|
|
|
| | T1 Global initiatives for the health related millennium development goals –
Needs for improved implementation
(Norwegian Forum for Global Health Research)
Room 1 | 14.30 – 16.00 | Workshop | | | Chairs: Gunnar Kvåle (Norway), Jon Øyvind Odland (Norway)
| |
| | Keynote Speakers:
|
| | David Sanders (South Africa)
Global health initiatives and the revised primary health care strategy: Conflicts or synergies?
| | | Bruno Marchal (Belgium)
Stimulating health workers to provide responsive care in low resource settings: Paying for performance won’t do the job on its own
| | | Gunnar Kvåle (Norway)
Measuring the effect of health interventions in complex settings: need for a common evaluation framework? | | |
|
|
|
|
|
| | T3P2 Tuberculosis
Room 3 | 14.30 – 16.00 | Parallel Session
| | | Chair and Keynote Speaker: Martin Boeree (The Netherlands)
Evidence based management of smear-negative TB | | | T3P2-01
The tuberculosis probability score as a helpful tool in the decision to treat for tuberculosis in smear negative and/or HIV positive patients
C. Magis-Escurra, A. Tostmann and M. Boeree
|
| | T3P2-02
Tuberculosis control: issues related to indigenous medical practitioners
S. Sweni, R. Meenakshisundaram and P. Thirumalaikolundusubramanian
|
| | T3P2-03
DOTS combined with social franchising as private public mix for the control of tuberculosis in Myanmar
A. N. Win, A. Wilder-Smith, A. Salim, N. N. Minn and A. N. Win |
| | T3P2-04
Treatment outcome of a cohort of Drug Resistant Tuberculosis patients in Yerevan (Armenia)
E. Sanchez |
| | T3P2-05
A ten-year experience of Childhood tuberculosis control programme in a rural hospital in Ethiopia
J. M. Ramos, F. Reyes and A. Tesfamariam | | | T3P2-06
Human genetic factors in pulmonary tuberculosis: candidate genes and a genome-wide association study
C. G. Meyer, T. Thye, C. Intemann, F. Herb, E. Owusu-Dabo, J. Gyapong, S. Niemann, F. Vannberg, R. Adegbola, S. Ehlers, A. Hill and R. Horstmann |
| | T3P2-07
An Antigen and Adjuvant System Dose Ranging Safety and Immunogenicity Study of the M72 Candidate Tuberculosis Vaccines in Healthy Filipino Adults
J. Montoya, J. A. Solon, L. Acosta, S. Cunanan, O. Ofori-Anyinam, C. Vinals, M.-A. Demoitie, P. Moris, M. Janssens, S. Gatchalian, H. Bock, D. Lapierre and J.Cohen |
| |
|
|
|
| | T4P2 Human African Trypanosomiasis
Room 4 | 14.30 – 16.00 | Parallel Session
| | | Chairs: August Stich (Germany), Krister Kristensson (Sweden)
|
|
| | Keynote Speakers: |
| | Marina Bentivoglio (Italy)
Trypanosoma brucei and the nervous system: Opportunities from fundamental research
|
| | Abdoulaye Diarra (World Health Organization)
Improving access to treatment for TB gambiense sleeping sickness
|
| | T4P2-01
The Atlas of human African trypanosomiasis
P. Simarro, G. Cecchi, J. Franco, M. Paone, A. Diarra, J. Ruiz and R. Mattioli
|
| | T4P2-02
A new format of the CATT test for the detection of Human African Trypanosomiasis, designed for use in peripheral health facilities
E. Hasker, P. Mitashi, R. Baelmans, P. Lutumba, D. Jacquet, V. Lejon, V. Kande, W. Van Der Veken, J. Declercq, M. Boelaert and P. Mitashi
| | | T4P2-03
Multicentre clinical trial of nifurtimox-eflornithine combination therapy for second-stage sleeping sickness
G. Priotto, S. Kasparian, W. Mutombo, D. Ngouama, S. Ghorashian, U. Arnold, S. Ghabri, E. Baudin, V. Buard, S. Kazadi-Kyanza, M. Ilunga, W. Mutangala, G. Pohlig, C. Schmid, U. Karunakara, E. Torreele and V. Kande |
| | T4P2-04
Perception of Human African Trypanosomiasis and participation in the control programme in the Kasaï Oriental province of D. R. Congo
A. Mpanya, D. Hendrickx, P. Mitashi, P. Lutumba, M. Boelaert and P. Lefèvre |
| | T4P2-05
Stamp out sleeping sickness – an intersectoral approach to disease control
S. Welburn | | | LBT4P2-06
Human African Trypanosomiasis: novel disease staging biomarkers
K. Kristensson, D. N. Amin, W. Masocha, D. Mumba, P. Buscher |
| |
|
|
|
| | T4 EU-CONTRAST optimizing schistosomiasis control in Sub -Saharan Africa
(Royal Society of Tropical Medicine and Hygiene)
Room 5 | 14.30 – 17.30 | Workshop | | | Chair: Russell Stothard (United Kingdom)
|
| | | Speakers: | | | David Rollinson (United Kingdom)
A new molecular epidemiology of African schistosomiasis with focus upon schistosome diversity
|
| | | Louis-Albert Tchueme-Tchuente (Cameroon)
Biological features of transmission and reinfection patterns of intestinal and urinary schistosomiasis after treatment
|
| | Christopher Simoonga (Zambia)
Mapping the spatial distribution of schistosomiasis and building an inclusive database of environmental information
| | | Juerg Utzinger (Switzerland)
Socio-economic analysis of the burden of schistosomiasis and monitoring behavioural change
|
| | Amadou Garba (Niger), Narcis Kabatereine (Uganda)
Towards better control of schistosomiasis and integration across other NTD programmes: challenges and solutions
| |
| Alan Fenwick (United Kingdom)
An update of global schistosomiasis treatments and unmet needs
| | |
|
|
|
| | T6 Surveillance for Emerging Tropical and Infectious Diseases (TropNetEurop)
Room 6 | 14.30 – 18.30 | Workshop | | | Chair: Guido Calleri (Italy)
|
| | | Speakers: |
| | Ron Behrens (United Kingdom)
Modelling malaria risk for travellers in the Amazon
|
| | Peter Chiodini (United Kingdom)
Fascioliasis due to chewing khat; an emerging imported disease in Britain |
| | Thomas Zoller (Germany)
Artesunate and treatment of complicated malaria in Europe
|
| | Johannes Blum (Switzerland)
Leishmaniasis: Species diagnosis and species oriented treatment
|
| | Antonio Tenorio (Spain)
Chikungunya and Dengue in European travellers | | | Tomas Jelinek (Germany)
10 years experience with imported Dengue Fever in Europe: summary of TropNetEurop data | | | Martin Grobusch (South Africa)
MalTHER: results of a TropNetEurop multi centred study on malaria treatment |
| |
|
|
|
| | Infectious disease control revisited :
Setting research priorities and arrangements
(facilitated by the European Commission – Directorate General for Research)
Room 7 | 14.30 – 16.00 | Round Table | | | Objectives:
- To promote the dialogue on the future direction of EU support for research on infectious disease control with the research community in general and with researchers from international partner countries in particular, as well as other stakeholders
- To encourage the scientific community to engage in a long term dialogue with the European Commission towards a problem and impact-oriented research agenda | | | | Chairs: María Guadalupe Guzmán (Cuba), Kevin McCarthy (European Commission, DG Research) |
|
| | Speakers: |
| | Marleen Boelaert (Belgium), Shyam Sundar (India)
Follow up of the EU-Conference on neglected infectious disease: conclusions and update | | | Bruno Gryseels (Belgium)
Follow up of the EU-Conference on poverty-related disease: conclusions and update | | | Panel:
Perspectives for future collaborative research: priority setting process, partnership arrangements, sustainable capacity building
Discussants:
Nick White (Thailand), Shyam Sundar (India), Mamadou Traore (Mali), Hector Hugo García (Peru), Rob Ridley (World Health Organization/TDR), Bruno Gryseels (Belgium), Ana Nieto (European Commission) | | | Rapporteurs:
Rose Mpembeni (Tanzania) and Pascal Lutumba (Congo) | | |
|
|
|
| | T2P2 Antimalarial Treatments : Registration & Beyond
Auditorium | 16.30 – 18.30 | Parallel Session | | | Introduction by Chair: Piero Olliaro (World Health Organization)
The global antimalarial portfolio (products in use and under clinical development) | | | | Keynote Speaker:
Henri Vial (France)
Beyond ACT: promising candidates | | | T2P2-01
Artemisinin-based Combination Therapy deployment in sub-Saharan countries – Antimalarial prescriptions: Practices to improve
S. Sarrassat, R. Lalou and J. Y. Le Hesran |
| | T2P2-02
A randomized trial to monitor the efficacy and effectiveness by QTNASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
P. F. Mens, H. Schallig, P. Sawa and P. A. Kager |
| | T2P2-03 Similar efficacy of artemether-lumefantrine and double dose chloroquine
in Guinea-Bissau
J. Ursing, P.-E. Kofoed, A. Rodrigues, R. Thoft Nielsen and L. Rombo |
| | T2P2-04
Efficacy and safety of artemether-lumefantrine dispersible tablet according to body weight in African infants and children with uncomplicated malaria: results of a multinational, randomised trial
U. D’Alessandro, A. Nahum, J. Lyimo, L. Otieno, H. Maiga, M. Bashraheil, S. Machevo, P. Ouma, H. Makame, N. Mulure, O. Nwaiwu and M. Cousin |
| | T2P2-05
Efficacy of a 3-day artesunate-mefloquine combination implemented for the treatment of uncomplicated falciparum malaria patients in 6 sentinel sites in Thailand
K. Congpuong, S. Intanakom, A. Pinyoratanachote, S. Cholpol, V. Bamroongpong, C. Chompoonuch and V. Lailang
|
| | T2P2-06
Efficacy and safety of pyronaridine/artesunate fixed-dose combination compared with mefloquine plus artesunate in patients with acute uncomplicated Plasmodium falciparum malaria: results of a pivotal Phase III trial
R. Rueangweerayut, A. Pyae Phyo, C. Uthaisin, D. Socheat, T. Quang Binh, H. Tinto, L. Penali, N. Valecha, S. Abdulla, N. Thi Tien, I. Borghini-Fuhrer and C.-S. Shin
|
| | T2P2-07
Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based prospective, exposed/non exposed to fever, study
in Benin
J.-F. Faucher, P. Makoutode, G. Abiou, T. Beheton, A. Aubouy, J. Doritchamou, P. Houze, E. Ouendo, S. Houze, P. Deloron and M. Cot |
| | T2P2-08
Massive reduction of antimalarial prescriptions during programmatic implementation of Rapid Diagnostic Tests in Dar es Salaam, Tanzania
V. D’Acremont, J. Kahama-Maro, N. Swai, D. Mtasiwa, B. Genton and C. Lengeler |
| |
|
|
|
| | T1 The North -South differences in medical publishing : time for an action ?
Round table organised by the Editorial team ,
Tropical Medicine and International Health (TMIH)
Room 1 | 16.30 – 18.30 | Round Table | | | | Moderators: Thomas Junghanss (TMIH, Germany), Susanne Groener (TMIH, United Kingdom) | |
| | Discussants:
Ricardo Lourenço-de-Oliveira, Editor, Memórias do Instituto Oswaldo Cruz (Brazil); Hooman Momen, Editor, Bulletin of the World Health Organization (World Health Organization); Domhnall McAuley, British Medical Journal (United Kingdom); Ajit Lalvani (United Kingdom); Fred Binka (Ghana) |
| |
|
|
|
|
|
| | T5P1 Child Health in the International Agenda
Room 3 | 16.30 – 17.30 | Parallel Session | | | | Chair: Giorgio Tamburlini (Italy) | | | | Keynote Speakers: | | | | David Sanders (South Africa)
Revitalisation of Primary Health Care: Opportunities and challenges of child survival
|
| | Giorgio Tamburlini (Italy)
Assessing and improving the quality of child care in hospital and in primary care
| | |
|
|
|
| | T4 Poverty, Inequity and Bacterial Resistance Joint Session FESMTIH – ESCMID
Room 4 | 16.30 – 17.30 | Workshop | | | Chair: Giuseppe Cornaglia (Italy)
Overview of the problem of bacterial resistance on a global scale
|
| | | Speakers: | | | Alessandro Bartoloni (Italy)
The high burden of bacterial resistance in resource limited settings
| | | Eduardo Gotuzzo (Peru)
The role of poverty and inequity in promoting bacterial resistance |
| |
|
|
|
| | T1P2 Ethical Issues in Clinical Research
Room 3 | 17.30 – 18.30 | Parallel Session | | | | Chair: Pascal Lutumba (Congo) |
| | | T1P2-01
Ethical Principles and Practices in Clinical Research: an explorative survey
B. Roels |
| | T1P2-02
Informed consent, decision-making capacity and vulnerability in resource
constrained settings
T. Halidou, A. Talisuna, N. Rouamba, Y. Adoke, K. Peeters Grietens, U. D’Alessandro and R. Ravinetto
| | | T1P2-03
Rationalising international approaches to ethical review: examining and revising the ethical review practices for clinical research funded, sponsored or carried out by Northern organizations in developing countries
R. Ravinetto, A. Buvé, P. Lutumba, V. Maketa, A. Ebeja Kadima, P. Cras and F. P. Crawley | | | T1P2-04
Ethics and clinical research in Democratic Republic of Congo (DRC)
V. Maketa, A. Ebeja, M. Boelaert, R. Ravinetto and P. Lutumba
| | | T1P2-05
Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers
P. Calain, N. Fiore, M. Poncin and S. Hurst | | | T1P2-06
Clinical research in less economically developed countries: the ethical challenges
A.L: Knellwolf, S. Bauzon, P. Panei, R. Arcieri, S. Vella, D. Alfarez and A. Meyerhans |
| |
|
|
|
| | T4 Preventive chemotherapy for Neglected Tropical Diseases: a vertical or horizontal approach?
Room 4 | 17.30 – 18.30 | Debate
| | | Moderator:
Marleen Boelaert (Belgium) |
| | | Discussants:
Els Mathieu (United States), Anna Cavalli (Italy) | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
